Search

Search Constraints

You searched for: Author/Creator Xiao, Nan

Search Results

9. A randomized, double-blind, single-dose, parallel phase I clinical trial to compare the bioequivalence, immunogenicity, and safety of bevacizumab biosimilar and bevacizumab in healthy Chinese subjects. (3rd August 2022)